2,710
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

, , , , , , , , , , , , & show all
Article: 2247053 | Received 19 Jan 2023, Accepted 08 Aug 2023, Published online: 24 Aug 2023

References

  • Frostegård J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med. 2023;293(1):48–25. doi:10.1111/joim.13557.
  • Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol. 2003;30:493–496.
  • Wolf VL, Ryan MJ. Autoimmune disease-associated hypertension. Curr Hypertens Rep. 2019;21(1):10. doi:10.1007/s11906-019-0914-2.
  • Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713–735. doi:10.1161/CIRCRESAHA.116.309326.
  • Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Zarzuelo MJ, Gómez-Morales M, O’Valle F, López-Farré AJ, Algieri F, Gálvez J, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2014;64(2):330–337. doi:10.1161/HYPERTENSIONAHA.114.03587.
  • Hevia A, Milani C, López P, Cuervo A, Arboleya S, Duranti S, Turroni F, González S, Suárez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio. 2014;5(5). doi:10.1128/mBio.01548-14.
  • López P, Sánchez B, Margolles A, Suárez A. Intestinal dysbiosis in systemic lupus erythematosus: cause or consequence? Curr Opin Rheumatol. 2016;28(5):515–522. doi:10.1097/BOR.0000000000000309.
  • Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus. Mol Med. 2019;25(1):35. doi:10.1186/s10020-019-0102-5.
  • Luo XM, Edwards MR, Mu Q, Yu Y, Vieson MD, Reilly CM, Ahmed SA, Bankole AA, McBain AJ. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol. 2018;84(4):84. doi:10.1128/AEM.02288-17.
  • Zhang H, Liao X, Sparks JB, Luo XM, Schloss PD. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551–7560. doi:10.1128/AEM.02676-14.
  • Mu Q, Tavella VJ, Kirby JL, Cecere TE, Chung M, Lee J, Li S, Ahmed SA, Eden K, Allen IC, et al. Antibiotics ameliorate lupus-like symptoms in mice. Sci Rep. 2017;7(1):1–14. doi:10.1038/s41598-017-14223-0.
  • Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. doi:10.1186/s40168-017-0300-8.
  • Katz-Agranov N, Zandman-Goddard G. The microbiome and systemic lupus erythematosus. Immunol Res. 2017;65(2):432–437. doi:10.1007/s12026-017-8906-2.
  • Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Sci. 2018;359(6380):1156–1161. doi:10.1126/science.aar7201.
  • Zegarra-Ruiz DF, El Beidaq A, In AJ, Greiling TM, Dehner C, Kriegel MA, Lubrano M, Ricco D, Zegarra-Ruiz DF, El Beidaq A, et al. A diet-sensitive commensal lactobacillus strain article a diet-Sensitive commensal Lactobacillus strainmediates TLR7-dependent systemic autoimmunity. Cell Host & Microbe. 2019;25(1):113–127.e6. doi:10.1016/j.chom.2018.11.009.
  • Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:10.1186/s40168-016-0222-x.
  • de la Visitación N, Robles-Vera I, Toral M, Gómez-Guzmán M, Sánchez M, Moleón J, González-Correa C, Martín-Morales N, O’Valle F, Jiménez R, et al. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus. Br J Pharmacol. 2021;178(18):3708–3729. doi:10.1111/bph.15512.
  • de la Visitación N, Robles-Vera I, Moleón J, González-Correa C, Aguilera-Sánchez N, Toral M, Gómez-Guzmán M, Sánchez M, Jiménez R, Martin-Morales N, et al. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in Toll-like receptor 7-driven lupus autoimmunity. Antioxidants (Basel, Switzerland). 2021;10(9):1426. doi:10.3390/antiox10091426.
  • Karbach SH, Schönfelder T, Brandão I, Wilms E, Hörmann N, Jäckel S, Schüler R, Finger S, Knorr M, Lagrange J, et al. Gut microbiota Promote angiotensin II–induced arterial hypertension and vascular dysfunction. J Am Heart Assoc. 2016;5(9):e003698. doi:10.1161/JAHA.116.003698.
  • Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, Haase S, Mähler A, Balogh A, Markó L, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551(7682):585–589. doi:10.1038/nature24628.
  • Toral M, Robles-Vera I, Romero M, de la Visitacion N, Sanchez M, O’Valle F, Rodriguez-Nogales A, Galvez J, Duarte J, Jimenez R. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J Off Publ Fed Am Soc Exp Biol. 2019;33(9):10005–10018. doi:10.1096/fj.201900545RR.
  • de la Visitación N, Robles-Vera I, Toral M, O’Valle F, Moleon J, Gómez-Guzmán M, Romero M, Duarte M, Sánchez M, Jiménez R, et al. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus. Food Funct. 2020;11(6):5266–5274. doi:10.1039/D0FO00578A.
  • Elkan A-C, Anania C, Gustafsson T, Jogestrand T, Hafström I, Frostegård J. Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis. Lupus. 2012;21(13):1405–1411. doi:10.1177/0961203312458471.
  • Schäfer A-L, Eichhorst A, Hentze C, Kraemer AN, Amend A, Sprenger DTL, Fluhr C, Finzel S, Daniel C, Salzer U, et al. Low dietary fiber intake links development of obesity and lupus pathogenesis. Front Immunol. 2021;12:696810. doi:10.3389/fimmu.2021.696810.
  • Minami Y, Hirabayashi Y, Nagata C, Ishii T, Harigae H, Sasaki T. Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients. J Epidemiol. 2011;21(4):246–254. doi:10.2188/jea.JE20100157.
  • Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, et al. Deficiency of prebiotic fiber and Insufficient Signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation. 2020;141(17):1393–1403. doi:10.1161/CIRCULATIONAHA.119.043081.
  • Marques FZ, Nelson E, Chu P-Y, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964–977. doi:10.1161/CIRCULATIONAHA.116.024545.
  • Wang L, Zhu Q, Lu A, Liu X, Zhang L, Xu C, Liu X, Li H, Yang T. Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin–angiotensin system. J Hypertens. 2017;35(9):1899–1908. doi:10.1097/HJH.0000000000001378.
  • Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132(6):701–718. doi:10.1042/CS20180087.
  • Bartolomaeus H, Balogh A, Yakoub M, Homann S, Markó L, Höges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652.
  • Robles-Vera I, de la Visitación N, Toral M, Sánchez M, Romero M, Gómez-Guzmán M, Yang T, Izquierdo-García JL, Guerra-Hernández E, Ruiz-Cabello J, et al. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension. FASEB J Off Publ Fed Am Soc Exp Biol. 2020;34(10):13626–13640. doi:10.1096/fj.202001532R.
  • Robles-Vera I, Toral M, de la Visitación N, Sánchez M, Gómez-Guzmán M, Romero M, Yang T, Izquierdo-Garcia JL, Jiménez R, Ruiz-Cabello J, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: Role of Short-chain fatty acids. Mol Nutr Food Res. 2020;64(6):e1900616. doi:10.1002/mnfr.201900616.
  • Ryan MJ, McLemore GRJ. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R736–42. doi:10.1152/ajpregu.00168.2006.
  • Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B. The heart in hypertension. N Engl J Med. 1992;327(14):998–1008. doi:10.1056/NEJM199210013271406.
  • Wofsy D, Chiang NY, Greenspan JS, Ermak TH. Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects on the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease. J Autoimmun. 1988;1(5):415–431. doi:10.1016/0896-8411(88)90065-0.
  • Dorraji SE, Kanapathippillai P, Hovd A-M, Stenersrød MR, Horvei KD, Ursvik A, Figenschau SL, Thiyagarajan D, Fenton CG, Pedersen HL, et al. Kidney Tertiary lymphoid Structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature. Am J Pathol. 2020;190(11):2203–2225. doi:10.1016/j.ajpath.2020.07.015.
  • Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9(1):243–269. doi:10.1146/annurev.iy.09.040191.001331.
  • Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227. doi:10.1136/gut.28.10.1221.
  • Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP. Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate. J Physiol. 1998;513(3):719–732. doi:10.1111/j.1469-7793.1998.719ba.x.
  • Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Corrigendum: Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:1486. doi:10.3389/fimmu.2019.01486.
  • Park J-H, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, Usui Y, Hatano N, Shinohara M, Saito Y, et al. Promotion of intestinal epithelial cell turnover by commensal bacteria: Role of Short-chain fatty acids. PLoS One. 2016;11(5):e0156334. doi:10.1371/journal.pone.0156334.
  • Kelly CJ, Colgan SP. Breathless in the gut: Implications of Luminal O2 for microbial pathogenicity. Cell Host & Microbe. 2016;19(4):427–428. doi:10.1016/j.chom.2016.03.014.
  • González-Bosch C, Boorman E, Zunszain PA, Mann GE. Short-chain fatty acids as modulators of redox signaling in health and disease. Redox Biol. 2021;47:102165. doi:10.1016/j.redox.2021.102165.
  • Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine. 2015;72(2):146–153. doi:10.1016/j.cyto.2014.12.027.
  • Dar O, Salaman MR, Seifert MH, Isenberg DA. B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clin Exp Immunol. 1988;73:430–435.
  • Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Sci. 2005;307(5707):254–258. doi:10.1126/science.1102901.
  • Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122(24):2529–2537. doi:10.1161/CIRCULATIONAHA.109.930446.
  • Mora JR, von Andrian UH. Differentiation and homing of IgA-secreting cells. Mucosal Immunol. 2008;1(2):96–109. doi:10.1038/mi.2007.14.
  • Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830–1835. doi:10.1002/eji.201040391.
  • Chen X, Su W, Wan T, Yu J, Zhu W, Tang F, Liu G, Olsen N, Liang D, Zheng SG. Sodium butyrate regulates Th17/Treg cell balance to ameliorate uveitis via the Nrf2/HO-1 pathway. Biochem Pharmacol. 2017;142:111–119. doi:10.1016/j.bcp.2017.06.136.
  • MacKay CE, Shaifta Y, Snetkov VV, Francois AA, Ward JPT, Knock GA. ROS-dependent activation of RhoA/Rho-kinase in pulmonary artery: Role of src-family kinases and ARHGEF1. Free Radic Biol Med. 2017;110:316–331. doi:10.1016/j.freeradbiomed.2017.06.022.
  • Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol. 2013;33(4):777–784. doi:10.1161/ATVBAHA.112.301087.
  • Robles-Vera I, Toral M, de la Visitación N, Aguilera-Sánchez N, Redondo JM, Duarte J. Protective effects of Short-chain fatty acids on endothelial dysfunction induced by angiotensin II. Front Physiol. 2020;11:277. doi:10.3389/fphys.2020.00277.
  • Taylor EB, Ryan MJ. Understanding mechanisms of hypertension in systemic lupus erythematosus. Ther Adv Cardiovasc Dis. 2016;11(1):20–32. doi:10.1177/1753944716637807.
  • de la Visitación N, Robles-Vera I, Toral M, Duarte J. Protective effects of probiotic consumption in cardiovascular disease in systemic lupus erythematosus. Nutrients. 2019;11:2676. doi:10.3390/nu11112676.
  • Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(5):1469–1476. doi:10.1099/ijs.0.02873-0.
  • Catry E, Bindels LB, Tailleux A, Lestavel S, Neyrinck AM, Goossens J-F, Lobysheva I, Plovier H, Essaghir A, Demoulin J-B, et al. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut. 2018;67(2):271–283. doi:10.1136/gutjnl-2016-313316.
  • Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia muciniphila protects against atherosclerosis by Preventing metabolic endotoxemia-induced inflammation in Apoe −/− mice. Circulation. 2016;133(24):2434–2446. doi:10.1161/CIRCULATIONAHA.115.019645.
  • Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, et al. Potential relevance of α1-adrenergic receptor autoantibodies in Refractory hypertension. PLoS One. 2008;3(11):e3742. doi:10.1371/journal.pone.0003742.
  • Romero M, Toral M, Robles-Vera I, Sanchez M, Jimenez R, O’Valle F, Rodriguez-Nogales A, Perez-Vizcaino F, Galvez J, Duarte J. Activation of peroxisome proliferator activator receptor β/δ Improves endothelial dysfunction and protects kidney in murine lupus. Hypertension. 2017;69(4):641–650. doi:10.1161/HYPERTENSIONAHA.116.08655.
  • Kelley VR, Wuthrich RP. Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol. 1999;19:57–66.
  • Ryan MJ. An update on immune system activation in the pathogenesis of hypertension. Hypertension. 2013;62(2):226–230. doi:10.1161/HYPERTENSIONAHA.113.00603.
  • Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res. 2013;97(4):696–704. doi:10.1093/cvr/cvs422.
  • Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CRW. Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species. J Vasc Res. 2011;48(1):52–58. doi:10.1159/000317400.
  • Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med. 1992;152(10):2082–2088. doi:10.1001/archinte.1992.00400220098017.
  • Petrin J, Rozman B, Dolenc P, Logar D, Bozic B, Vizjak A, Ferluga D, Jezersek P. The dissociation of arterial hypertension and lupus glomerulonephritis in systemic lupus erythematosus. Blood Press. 1993;2(2):108–112. doi:10.3109/08037059309077537.
  • Shaharir SS, Mustafar R, Mohd R, Mohd Said MS, Gafor HA. Persistent hypertension in lupus nephritis and the associated risk factors. Clin Rheumatol. 2015;34(1):93–97. doi:10.1007/s10067-014-2802-0.
  • Beale AL, Kaye DM, Marques FZ. The role of the gut microbiome in sex differences in arterial pressure. Biol Sex Differ. 2019;10(1):22. doi:10.1186/s13293-019-0236-8.
  • Marques FZ, Jama HA, Tsyganov K, Gill PA, Rhys-Jones D, Muralitharan RR, Muir J, Holmes A, Mackay CR. Guidelines for transparency on gut microbiome studies in essential and experimental hypertension. Hypertens (Dallas, Tex 1979). 2019;74(6):1279–1293. doi:10.1161/HYPERTENSIONAHA.119.13079.
  • Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol. 2020;177(16):3617–3624. doi:10.1111/bph.15193.
  • Hill GS, Delahousse M, Nochy D, Bariéty J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 2005;68(5):2288–2297. doi:10.1111/j.1523-1755.2005.00688.x.
  • Zhao S, Li L. Dansylhydrazine isotope labeling LC-MS for comprehensive carboxylic acid submetabolome profiling. Anal Chem. 2018;90(22):13514–13522. doi:10.1021/acs.analchem.8b03435.
  • Toral M, Romero M, Rodriguez-Nogales A, Jimenez R, Robles-Vera I, Algieri F, Chueca-Porcuna N, Sanchez M, de la Visitacion N, Olivares M, et al. Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving eNOS Coupling. Mol Nutr Food Res. 2018;62(14):e1800033. doi:10.1002/mnfr.201800033.
  • Dole VS, Henderson KS, Fister RD, Pietrowski MT, Maldonado G, Clifford CB. Pathogenicity and genetic variation of 3 strains of Corynebacterium bovis in immunodeficient mice. J Am Assoc Lab Anim Sci. 2013;52:458–466.
  • Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA. 2011;108(supplement_1):4516–4522. doi:10.1073/pnas.1000080107.
  • Zhou H-W, Li D-F, Tam NFY, Jiang X-T, Zhang H, Sheng H-F, Qin J, Liu X, Zou F. BIPES, a cost-effective high-throughput method for assessing microbial diversity. ISME J. 2011;5(4):741–749. doi:10.1038/ismej.2010.160.
  • Liu Z, Liu H-Y, Zhou H, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 2017;8:1687. doi:10.3389/fmicb.2017.01687.
  • Edgar RC, Flyvbjerg H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics. 2015;31(21):3476–3482. doi:10.1093/bioinformatics/btv401.
  • Zeng Q, Li D, He Y, Li Y, Yang Z, Zhao X, Liu Y, Wang Y, Sun J, Feng X, et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci Rep. 2019;9(1):13424. doi:10.1038/s41598-019-49462-w.
  • Xia WJ, Xu ML, Yu XJ, Du MM, Li XH, Yang T, Li L, Li Y, Kang KB, Su Q, et al. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat. Gut Microbes. 2021;13(1):1–24. doi:10.1080/19490976.2020.1854642.